AstraZeneca's heart drug gets FDA nod

AstraZeneca Plc said on Monday the U.S. Food and Drug Administration has approved its drug for reducing the risk of a first heart attack or stroke in high-risk patients with coronary artery disease.

from Reuters: Health News https://ift.tt/2MdXVz8
via IFTTT